BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Btissame El Hassouni, Dzjemma Sarkisjan, J. Chris Vos, Elisa Giovannetti, Godefridus J. Peters. Targeting the Ribosome Biogenesis Key Molecule Fibrillarin to Avoid ChemoresistanceCurrent Medicinal Chemistry 2019; 26(33): 6020 doi: 10.2174/0929867326666181203133332
2
Nahla E. El‐Ashmawy, Ghada M. Al‐Ashmawy, Sara M. Hamouda. Long non‐coding RNA FAM83H‐AS1 as an emerging marker for diagnosis, prognosis and therapeutic targeting of cancer Cell Biochemistry and Function 2020;  doi: 10.1002/cbf.3601
3
Roberta Peruzzo, Andrea Mattarei, Matteo Romio, Cristina Paradisi, Mario Zoratti, Ildikò Szabò, Luigi Leanza. Regulation of Proliferation by a Mitochondrial Potassium Channel in Pancreatic Ductal Adenocarcinoma CellsFrontiers in Oncology 2017; 7 doi: 10.3389/fonc.2017.00239
4
Herve Tiriac, Juan Carlos Bucobo, Demetrios Tzimas, Suman Grewel, Joseph F. Lacomb, Leahana M. Rowehl, Satish Nagula, Maoxin Wu, Joseph Kim, Aaron Sasson, Shivakumar Vignesh, Laura Martello, Maria Munoz-Sagastibelza, Jonathan Somma, David A. Tuveson, Ellen Li, Jonathan M. Buscaglia. Successful creation of pancreatic cancer organoids by means of EUS-guided fine-needle biopsy sampling for personalized cancer treatmentGastrointestinal Endoscopy 2018; 87(6): 1474 doi: 10.1016/j.gie.2017.12.032
5
Zengyu Feng, Minmin Shi, Kexian Li, Yang Ma, Lingxi Jiang, Hao Chen, Chenghong Peng. Development and validation of a cancer stem cell-related signature for prognostic prediction in pancreatic ductal adenocarcinomaJournal of Translational Medicine 2020; 18(1) doi: 10.1186/s12967-020-02527-1
6
Ning Pu, Yang Lv, Guochao Zhao, Wanling Lee, Abulimiti Nuerxiati, Dansong Wang, Xuefeng Xu, Tiantao Kuang, Wenchuan Wu, Wenhui Lou. Survival prediction in pancreatic cancer patients with no distant metastasis: a large-scale population-based estimateFuture Oncology 2018; 14(2): 165 doi: 10.2217/fon-2017-0380
7
Md Asad Ullah, Bishajit Sarkar, Fayza Akter. Prediction of biomarker signatures and therapeutic agents from blood sample against Pancreatic Ductal Adenocarcinoma (PDAC): A network-based studyInformatics in Medicine Unlocked 2020; 19: 100346 doi: 10.1016/j.imu.2020.100346